Bortezomib and Rituximab for Patients With Waldenstrom's Macroglobulinemia
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Chicago
Gilead Sciences
University of Washington
Mayo Clinic
Acerta Pharma BV
Acerta Pharma BV
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Roswell Park Cancer Institute
City of Hope Medical Center
Janssen Pharmaceutical K.K.
University College, London
BeiGene
BeiGene
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
University of Rochester
Stanford University
Mayo Clinic
University of Nebraska
Weill Medical College of Cornell University
University of Nebraska
TG Therapeutics, Inc.
Abramson Cancer Center at Penn Medicine
Brown University
Karyopharm Therapeutics Inc
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Mayo Clinic
Dana-Farber Cancer Institute
Hackensack Meridian Health
National Cancer Institute (NCI)
Roswell Park Cancer Institute
Cancer Research UK
ADC Therapeutics S.A.
Barbara Ann Karmanos Cancer Institute
Dana-Farber Cancer Institute
Fred Hutchinson Cancer Center
Pharmacyclics LLC.
Dana-Farber Cancer Institute
Masonic Cancer Center, University of Minnesota
Dana-Farber Cancer Institute
Mayo Clinic
M.D. Anderson Cancer Center
Eli Lilly and Company
Dana-Farber Cancer Institute
Roswell Park Cancer Institute
Gilead Sciences
Pharmacyclics LLC.